Krsnaa Diagnostics Q2 FY26 Earnings Results

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.

 

Q2 FY26 Earnings Results for NSE: KRSNAA (Krsnaa Diagnostics Limited)

• Revenue from Operations: ₹183 crore, up 2.2% YoY from ₹179 crore in Q2 FY25

• EBITDA: ₹59.24 crore, up 19.9% YoY; EBITDA margin expanded by 222 bps to 28.74%

• Profit After Tax (PAT): ₹23 crore, up 4.5% YoY from ₹22 crore

• Net profit margin approximately 11.6%

• Total assets stood at ₹1506.69 crore; total equity at ₹922.95 crore

• Cash and cash equivalents: ₹10.56 crore

• Operating cash flow for H1 FY26: ₹51.87 crore

• Consistent growth in domestic and international markets with steady margin improvement

 

Management Commentary & Strategic Insights

• Management highlighted the company’s strong operational performance despite market volatility

• Expansion in diagnostic services supported by technology upgrades and increasing geographic reach

• Focus on maintaining cost efficiency, enhancing service capability, and expanding product offerings

• Long-term outlook remains positive with continued investments planned in diagnostic infrastructure

 

 

Q1 FY26 Earnings Results

• Revenue from Operations: ₹186.08 crore, up 13.36% YoY

• EBITDA: ₹25.63 crore, up 2.6% YoY; margin improving

• PAT: ₹20.52 crore, up 14.5% YoY

• Profit margin improvements attributed to efficiency gains and cost control

• Management emphasized sustained growth momentum and footprint expansion efforts

 

To view the company’s previous earnings and latest concall transcripts, click here  to visit the Alphastreet India news channel.